| Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc (NCT00755118) | University Hospital of Crete | 2008-10-01 |
| Radiofrequency Ablation in Resectable Colorectal Lung Metastasis (NCT00776399) | Mie University | 2008-10-01 |
| A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer (NCT00796718) | Hoffmann-La Roche | 2008-10-01 |
| Inflammatory Response in Laparoscopic and Open Colectomy (NCT00942461) | G. Hatzikosta General Hospital | 2008-10-01 |
| Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer (NCT00891332) | Taiho Pharmaceutical Co., Ltd. | 2008-10-01 |
| Trial of Aspirin and Arginine Restriction in Colorectal Cancer (NCT00578721) | University of California, Irvine | 2008-09-24 |
| Urine Metabolomics and Colorectal Cancer Screening (NCT01486745) | University of Alberta | 2008-09-15 |
| Prospective Randomized Comparison of Cold Snare Polypectomy and Conventional Polypectomy (NCT00763425) | Showa Inan General Hospital | 2008-09-01 |
| Nelfinavir, a Phase I/Phase II Rectal Cancer Study (NCT00704600) | Maastricht Radiation Oncology | 2008-09-01 |
| A Sustainable Approach to Increasing Cancer Screening (NCT01395459) | Harvard School of Public Health (HSPH) | 2008-09-01 |
| Validation of a Screening Tool in Geriatric Oncology (NCT00963911) | Institut Bergonié | 2008-08-05 |
| Longitudinal Study of Symptoms in Colorectal Cancer (NCT00777192) | M.D. Anderson Cancer Center | 2008-08-01 |
| Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. (NCT00974610) | Cancer Trials Ireland | 2008-08-01 |
| A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer (NCT00700570) | Hoffmann-La Roche | 2008-08-01 |
| Trial to Evaluate Laparoscopic Versus Open Surgery in Elderly Colorectal Cancer Patients (NCT01862562) | Shoichi Fujii, MD, PhD | 2008-08-01 |
| Cardiopulmonary Exercise Testing and Preoperative Risk Stratification (NCT00737828) | University College London Hospitals | 2008-08-01 |
| Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer (NCT00335816) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Psychosocial Adjustment After Radiation Therapy in Patients With Cancer (NCT00905086) | Case Comprehensive Cancer Center | 2008-08-01 |
| Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer (NCT00766155) | European Organisation for Research and Treatment of Cancer - EORTC | 2008-08-01 |
| Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer (NCT00726622) | Alliance for Clinical Trials in Oncology | 2008-08-01 |
| Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up (NCT00697047) | Kaiser Permanente | 2008-07-01 |
| A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer (NCT00943891) | National University Hospital, Singapore | 2008-07-01 |
| Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print (NCT01072851) | Trinity Health Of New England | 2008-07-01 |
| Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors (NCT00722228) | Hadassah Medical Organization | 2008-07-01 |
| Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation (NCT01262417) | Centre Leon Berard | 2008-07-01 |
| Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer (NCT00721916) | Taiho Pharmaceutical Co., Ltd. | 2008-07-01 |
| Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (NCT00797485) | Southern Italy Cooperative Oncology Group | 2008-07-01 |
| Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT00719797) | Gruppo Oncologico del Nord-Ovest | 2008-07-01 |
| Study of the Therapeutic Use of Language in Patients With Metastatic Colorectal Cancer (NCT00711672) | Hematology and Oncology Associates of NE Pennsylvania | 2008-07-01 |
| Interventions to Improve Colon Cancer Screening in Poor Rural Iowa Counties (NCT01477814) | Barcey T. Levy | 2008-07-01 |
| Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines (NCT01547923) | Institut Cancerologie de l'Ouest | 2008-06-16 |
| Application of CO2 Insufflations in Colonoscopy Randomized Trial (NCT00745927) | National Taiwan University Hospital | 2008-06-01 |
| S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000 (NCT00706121) | SWOG Cancer Research Network | 2008-06-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers (NCT00660153) | AVEO Pharmaceuticals, Inc. | 2008-06-01 |
| Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy (NCT00693290) | University of Ulster | 2008-06-01 |
| Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer (NCT00677443) | Samsung Medical Center | 2008-06-01 |
| Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients (NCT01361035) | Tulane University School of Medicine | 2008-06-01 |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT00655499) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2008-06-01 |
| Phase II Trial of LBH589 in Refractory Colorectal Cancer (NCT00690677) | Swedish Medical Center | 2008-06-01 |
| Micrometastasis in Gastrointestinal Cancer (NCT01919151) | Oslo University Hospital | 2008-06-01 |
| Colonography Versus Colonoscopy in High Risk Patient (NCT00748449) | Assistance Publique - Hôpitaux de Paris | 2008-06-01 |
| Standard Versus Advanced Antimicrobial Dressing Containing Ionic Silver Following Colorectal Cancer Surgery (NCT00981110) | European Institute of Oncology | 2008-06-01 |
| Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab (NCT00720512) | Gruppo Oncologico del Nord-Ovest | 2008-06-01 |
| Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized Study (NCT00624260) | Assistance Publique - Hôpitaux de Paris | 2008-06-01 |
| PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening (NCT00855348) | Epigenomics, Inc | 2008-06-01 |
| Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening (NCT01251666) | University Hospital, Caen | 2008-06-01 |
| Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis (NCT00743678) | Samsung Medical Center | 2008-06-01 |
| Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery (NCT00647530) | University of Birmingham | 2008-05-15 |
| Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer (NCT00640471) | NCIC Clinical Trials Group | 2008-05-12 |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer (NCT00677612) | Tokyo University | 2008-05-01 |
| A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer (NCT00642603) | Hoffmann-La Roche | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer (NCT00677287) | Tokyo University | 2008-05-01 |
| Safety Study of Modified Vaccinia Virus to Cancer (NCT00574977) | David Bartlett | 2008-05-01 |
| Trial of Second Generation Designer T Cells in Colorectal Carcinoma (NCT00673322) | Roger Williams Medical Center | 2008-05-01 |
| Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00703638) | Masonic Cancer Center, University of Minnesota | 2008-05-01 |
| Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST (NCT00979329) | Radboud University Medical Center | 2008-05-01 |
| Colorectal Cancer Screening for Cancer Survivors (NCT00982059) | University Health Network, Toronto | 2008-05-01 |
| Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project) (NCT01274143) | University of Utah | 2008-05-01 |
| Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer (NCT00613080) | Radiation Therapy Oncology Group | 2008-04-01 |
| The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients (NCT00859768) | Netherlands Open University | 2008-04-01 |
| Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer (NCT00681876) | Hellenic Oncology Research Group | 2008-04-01 |
| A Multi-Center Randomised Controlled Study to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer (NCT00788281) | Beijing Friendship Hospital | 2008-04-01 |
| Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer (NCT00677924) | Genmab | 2008-04-01 |
| Focusing Implementation to Bring Effective Reminders (FIBER) (NCT00656838) | Kaiser Permanente | 2008-04-01 |
| Efficacy of Vitamin D in Colorectal Cancer Chemoprevention (NCT01574027) | University of Illinois at Chicago | 2008-04-01 |
| Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy (NCT00713128) | Steward St. Elizabeth's Medical Center of Boston, Inc. | 2008-04-01 |
| Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery (NCT00660894) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2008-04-01 |
| Scope Pilot Research Study (NCT00893503) | University of Alberta | 2008-04-01 |
| Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma (NCT00625183) | Roswell Park Cancer Institute | 2008-03-01 |
| Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer (NCT00656123) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-03-01 |
| Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer (NCT00740961) | Case Comprehensive Cancer Center | 2008-03-01 |
| A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment (NCT00809796) | Oncozyme Pharma Inc. | 2008-03-01 |
| Energy Balance Interventions for Colorectal Cancer Prevention (NCT00653484) | Vanderbilt University | 2008-03-01 |
| Efficacy of the Third Eye Retroscope Auxiliary Imaging System (NCT00657371) | M.D. Anderson Cancer Center | 2008-03-01 |
| RCT of Air Insufflation Versus Water Infusion Colonoscopy (NCT00785889) | East Bay Institute for Research and Education | 2008-03-01 |
| Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab (NCT00588900) | Alliance for Clinical Trials in Oncology | 2008-03-01 |
| A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer (NCT00623805) | Hoffmann-La Roche | 2008-03-01 |
| Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer (NCT00749450) | Cancer Research UK, Glasgow | 2008-03-01 |
| Increasing Colorectal Cancer Screening in Urban African American Communities Via Churches (NCT01139242) | University of North Carolina, Chapel Hill | 2008-02-01 |
| OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum. (NCT00577031) | Hoffmann-La Roche | 2008-02-01 |
| NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b) (NCT00598975) | Nektar Therapeutics | 2008-02-01 |
| Increasing Colorectal Cancer Screening in African Americans (NCT00893295) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-02-01 |
| Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer (NCT00612586) | Eli Lilly and Company | 2008-02-01 |
| Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom (NCT00757965) | Cancer Research UK | 2008-02-01 |
| Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer (NCT00769405) | UNICANCER | 2008-02-01 |
| Screening for Familial Colorectal Cancer (CRC) Patients (NCT00632515) | M.D. Anderson Cancer Center | 2008-01-29 |
| AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer (NCT00535353) | NCIC Clinical Trials Group | 2008-01-02 |
| Interactive Computer Program or Brochure in Increasing Colorectal Cancer Screening Among African Americans (NCT00672828) | Indiana University | 2008-01-01 |
| Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis (NCT00630045) | Peking University People's Hospital | 2008-01-01 |
| Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis (NCT05462470) | Fudan University | 2008-01-01 |
| Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer (NCT00874406) | Fudan University | 2008-01-01 |
| Oxidative Stress Markers in Open and Laparoscopic Colectomy for Cancer (NCT00928928) | G. Hatzikosta General Hospital | 2008-01-01 |
| Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer (NCT00868569) | Fudan University | 2008-01-01 |
| Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers (NCT00594529) | Kyoto University | 2008-01-01 |
| Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study (NCT00630786) | Amgen | 2008-01-01 |
| Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer (NCT00479752) | Central European Cooperative Oncology Group | 2008-01-01 |
| Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients (NCT00574353) | Memorial Sloan Kettering Cancer Center | 2007-12-11 |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. (NCT00577109) | Hoffmann-La Roche | 2007-12-01 |
| Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer (NCT00544700) | Swiss Cancer Institute | 2007-11-26 |